Graphite Bio, Inc. has filed a registration statement on Form S-4 with the SEC for a proposed merger with Lenz Therapeutics, Inc., and is facing litigation and demand letters related to the merger.
AI Assistant
LENZ THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.